The U.S. company Aditum Bio and Chinese company Leads Biolabs today announced that they have founded Oblenio Bio, a new ...

The US biopharma will discontinue development of the Exondys 51 (eteplirsen) follow up treatment to focus on other treatment ...

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

The Dutch biotech Synaffix and the Swiss company BigHat Biosciences announced yesterday that they have entered into a ...

New Darzelex SC quadruplet regimen approved by European Commission for newly diagnosed multiple myeloma patients.

UK-based private biotech company Ottimo Pharma has emerged from stealth mode after four years with the appointment of a ...

The U.S. contract development and manufacturing organization (CDMO) Abzena announced yesterday that it has significantly ...

Vicky Marriott’s journey from enjoying school math to heading a global team of statisticians at Phastar reveals her belief in ...

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in ...

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...

The acquisition of Aliada Therapeutics will grant AbbVie access to a neuroscience-focused technology platform and an ...